Synthetic Bone Graft Substitutes Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Powered by ![]()
All the vital news, analysis, and commentary curated by our industry experts.
Synthetic Bone Graft Substitutes Pipeline Market Report Overview
Synthetic bone graft substitutes are used as alternatives for autograft and allograft bone. Major types of synthetic bone substitutes include calcium sulfate, calcium phosphate, tricalcium phosphate (TCP), and coralline hydroxyapatite. The second-generation products include bioactive glass, collagen-containing, and polymer-based bone substitutes.
The synthetic bone graft substitutes pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated with the trials.
| Key Territories | · The United States
· Europe · Taiwan · United Kingdom · Japan |
| Key Regulatory Paths | · 510(k)
· CE · PMA · BOPA · Ninsho |
| Leading Companies | · Acuitive Technologies Inc.
· Amend Surgical, Inc. · Anika Therapeutics Inc. · Baxter International Inc. · Bio2 Technologies Inc |
| Enquire & Decide | Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase. |
Synthetic Bone Graft Substitutes Pipeline Market Segmentation by Territories
The key territories associated with the synthetic bone graft substitute pipeline market are Europe, the United States, Taiwan, Japan, and the United Kingdom among others. As of October 2024, the US had the highest number of synthetic bone graft substitutes pipeline products.
Synthetic Bone Graft Substitutes Pipeline Market Analysis by Territories, 2024 (%)
Buy the Full Report for More Territory Insights into the Synthetic Bone Graft Substitutes Pipeline Market
Synthetic Bone Graft Substitutes Pipeline Market Segmentation by Regulatory Paths
A few of the key regulatory paths in the synthetic bone graft substitutes pipeline products market are 510(k), CE, PMA, BOPA, and Ninsho among others. As of October 2024, 510(k) was the most followed pathway for pipeline products in the synthetic bone graft substitutes market.
Synthetic Bone Graft Substitutes Pipeline Market Analysis by Regulatory Paths, 2024 (%)
Buy the Full Report for More Regulatory Path Insights into the Synthetic Bone Graft Substitutes Pipeline Market
Synthetic Bone Graft Substitutes Pipeline Market – Competitive Landscape
A few of the key companies associated with the synthetic bone graft substitutes pipeline market are Acuitive Technologies Inc., Amend Surgical, Inc., Anika Therapeutics Inc., Baxter International Inc., and Bio2 Technologies Inc. among others.
Acuitive Technologies Inc: Acuitive Technologies Inc. is a developer of surgical medical devices designed to help in surgeries. It is headquartered in Allendale, New Jersey, the US.
Baxter International Inc: Baxter International Inc. provides a range of healthcare products and services including sterile intravenous solutions, generic injectable pharmaceuticals, parenteral nutrition therapies, infusion systems and devices, inhaled anesthetics, and surgical hemostat and sealant products among others. Baxter distributes its products through a direct sales force and a network of independent distributors, drug wholesalers, specialty pharmacies, and other alternative site providers.
Key Companies in the Synthetic Bone Graft Substitutes Pipeline Market
Buy the Full Report for More Company Insights into the Synthetic Bone Graft Substitutes Pipeline Market
Download a Free Report Sample
Segments Covered in the Report
Synthetic Bone Graft Substitutes Pipeline Market Territories Outlook (2024)
- The United States
- Europe
- Taiwan
- United Kingdom
- Japan
Synthetic Bone Graft Substitutes Pipeline Market Regulatory Paths Outlook (2024)
- 510(k)
- CE
- PMA
- BOPA
- Ninsho
Scope
The report provides:
- Extensive coverage of the synthetic bone graft substitutes under development.
- Details of major pipeline products which include product description, licensing and collaboration details, and other developmental activities.
- Reviews of the major players involved in the development of synthetic bone graft substitutes and lists all their pipeline projects.
- Coverage of pipeline products based on various stages of development ranging from early development to approved/issued stage.
- Key clinical trial data of ongoing trials specific to pipeline products.
- Recent developments in the segment/industry.
Reasons to Buy
The report enables you to:
- Formulate significant competitor information, analysis, and insights to improve R&D strategies.
- Identify emerging players with potentially strong product portfolios and create effective counter strategies to gain competitive advantage.
- Identify and understand important and diverse types of synthetic bone graft substitutes under development.
- Develop market-entry and market-expansion strategies.
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.
- In-depth analysis of the product’s current stage of development, territory, and estimated launch date.
Agenta Biotechnologies Inc (Inactive)
Amend Surgical, Inc.
Anika Therapeutics Inc
Baxter International Inc
Berkeley Advanced Biomaterials Inc
Bio2 Technologies Inc
BioGend Therapeutics Co Ltd
Biomatlante SA
Biorez Inc
Bonalive Biomaterials Ltd
Bone Solutions Inc
BoneGrafix, Inc.
BoneSupport AB
Calcitec, Inc.
Daewoong Pharmaceutical Co Ltd
Dimension Inx LLC
DSM Biomedical BV
Elute Inc
Eskisehir Osmangazi University
EternoGen Aesthetics LLC
Graftys SA
Industrie Biomediche Insubri SA
Innovoss Inc. (Inactive)
IRCCS San Raffaele Hospital
Isto Biologics
King's College London
Maxigen Biotech Inc
National Center of Innovation for Biomaterials in Orthopaedic Research
National University of Science and Technology MiSiS
OrthoMedex LLC
OssDsign AB
PolyPid Ltd
Polytechnic University of Catalonia
Pro Therapeutics LLC
Promimic AB
Prosidyan, Inc.
ReCaPP
RepRegen Ltd. (Inactive)
Revivicor Inc
Sanara MedTech Inc
Scil Technology GmbH
SDIP Innovations Pty Ltd
Silk Biomaterials Srl
Sofregen Medical Inc
Soteira Inc
Sree Chitra Tirunal Institute for Medical Sciences & Technology
Stanford University
SurGenTec LLC
University of California San Diego
University of Edinburgh
Wright Medical Group NV (Inactive)
Xtant Medical Holdings Inc
Table of Contents
Table
Figures
Frequently asked questions
-
Which territory had the highest number of products in the synthetic bone graft substitutes pipeline market as of October 2024?
As of October 2024, the US had the highest number of synthetic bone graft substitutes pipeline products.
-
Which was the most followed regulatory pathway in the synthetic bone graft substitutes pipeline market as of October 2024?
As of October 2024, 510(k) was the most followed pathway for pipeline products in the synthetic bone graft substitutes market.
-
Which are the major companies operating in the synthetic bone graft substitutes pipeline market?
A few of the key companies associated with the synthetic bone graft substitutes pipeline market are Acuitive Technologies Inc., Amend Surgical, Inc., Anika Therapeutics Inc., Baxter International Inc., and Bio2 Technologies Inc., among others.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745

